A detailed history of Fmr LLC transactions in Liva Nova PLC stock. As of the latest transaction made, Fmr LLC holds 31,466 shares of LIVN stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,466
Previous 18,731 67.99%
Holding current value
$1.69 Million
Previous $1.03 Million 61.01%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$43.38 - $54.59 $552,444 - $695,203
12,735 Added 67.99%
31,466 $1.65 Million
Q2 2024

Aug 13, 2024

BUY
$51.76 - $64.15 $73,602 - $91,221
1,422 Added 8.22%
18,731 $1.03 Million
Q1 2024

May 13, 2024

BUY
$48.6 - $57.12 $32,173 - $37,813
662 Added 3.98%
17,309 $968,000
Q4 2023

Feb 13, 2024

SELL
$43.45 - $53.66 $75,429 - $93,153
-1,736 Reduced 9.44%
16,647 $861,000
Q3 2023

Nov 13, 2023

BUY
$50.12 - $58.87 $48,967 - $57,515
977 Added 5.61%
18,383 $972,000
Q2 2023

Aug 11, 2023

BUY
$42.28 - $51.43 $536,829 - $653,006
12,697 Added 269.63%
17,406 $895,000
Q1 2023

May 11, 2023

BUY
$40.84 - $58.14 $4,982 - $7,093
122 Added 2.66%
4,709 $205,000
Q4 2022

Feb 13, 2023

BUY
$43.88 - $56.16 $19,702 - $25,215
449 Added 10.85%
4,587 $254,000
Q3 2022

Nov 10, 2022

SELL
$48.37 - $66.5 $16 Million - $21.9 Million
-329,858 Reduced 98.76%
4,138 $210,000
Q2 2022

Aug 12, 2022

BUY
$57.25 - $86.63 $238,503 - $360,900
4,166 Added 1.26%
333,996 $20.9 Million
Q1 2022

May 13, 2022

BUY
$71.02 - $86.99 $23.4 Million - $28.7 Million
329,450 Added 86697.37%
329,830 $27 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $28,051 - $32,700
369 Added 3354.55%
380 $30,000
Q2 2021

Aug 13, 2021

BUY
$73.44 - $87.01 $807 - $957
11 New
11 $0

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.87B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.